证券日报网讯 1月28日，朗科科技在互动平台回答投资者提问时表示，公司于2026年1月21日披露业绩 预告，预计2025年归属于上市公司股东的净利润为2100万元至3100万元，同比扭亏为盈。公司重视存储 行业历史性机遇，将持续聚焦存储主业，继续推进降本增效、优化销售策略等经营举措，不断提升盈利 能力，积极回报投资者。 （文章来源：证券日报） ...

南财智讯1月28日电，方大特钢公告，预计2025年全年归属于上市公司股东的净利润为8.35亿元—9.98亿 元，同比预增236.90%—302.67%；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润 为7.05亿元—8.68亿元，同比预增299.87%—392.32%；主要变动原因为：2025年，钢铁行业下游需求仍 偏弱运行，钢材价格呈震荡下行态势，但同期上游主要原燃料价格也显著回落，钢材利润得到一定修 复。在生产端，公司持续推进精细化管理，大力降本增效；建设两套65MW超高温亚临界发电项目，提 升能源利用效率。在销售端，公司抢抓市场机遇，通过优化品种结构，提高高效益产品产销量，有力推 动了业绩增长；2025年，公司非经常性损益金额约为13,000万元，主要原因是受资本市场整体上涨影 响，公司投资的信托产品等公允价值变动收益增加；2024年同期，公司非经常性损益金额为7,154.07万 元。 ...

格隆汇1月28日丨天沃科技（维权）(002564.SZ)公布，预计2025年归属于上市公司股东的净利润 3,500.00万元–5,000.00万元，比上年同期增长45.60%-108.00%，扣除非经常性损益后的净利润5,200.00万 元–7,800.00万元。报告期内，公司紧密围绕年度目标，大力推进降本增效工作，本期财务费用较上年同 期有所下降；同时，公司持续夯实资产质量，盘活存量低效资产，优化资产配置结构，加大应收账款催 收力度，实现经营性现金流净流入，归属于上市公司股东的净利润实现同比增长。 ...

Core Viewpoint - Hongsheng Huayuan (601096.SH) expects a net profit attributable to shareholders of 348 million to 400 million yuan for 2025, representing a year-on-year increase of 51.22% to 73.82% [1] Group 1: Financial Performance - The anticipated profit growth is primarily driven by continuous cost reduction and efficiency improvement, leading to a significant increase in gross margin [1] - Revenue growth from international business has contributed positively to the profit [1] - The subsidiary's land reserve has generated asset disposal income, further enhancing profitability [1]

Core Viewpoint - Matrix Co., Ltd. (301365.SZ) expects a net profit attributable to shareholders of 58 million to 80 million yuan for the year 2025, representing an increase of 72.12% to 137.40% compared to the previous year. The net profit after deducting non-recurring gains and losses is projected to be 48 million to 70 million yuan, reflecting a significant increase of 358.71% to 568.95% year-on-year [1]. Group 1: Performance Expectations - The company anticipates a substantial increase in net profit for 2025, with projections indicating a rise of up to 137.40% compared to the previous year [1]. - The expected net profit after excluding non-recurring items shows an even more dramatic increase, suggesting strong operational performance [1]. Group 2: Reasons for Performance Changes - The transition of China's real estate market from rapid growth to stable development continues to support the importance of residential real estate in driving economic growth and improving living standards [1]. - The company has focused on brand building and market expansion, which has led to increased business revenue and optimized team configuration [1]. - Strict cost control measures have been implemented, contributing to the increase in net profit compared to the previous year [1]. - Enhanced management of accounts receivable has accelerated collection speeds and effectively controlled bad debt losses [1]. - Non-recurring gains for 2025 include income from cash management, reversals of impairment provisions for receivables, and one-time share-based payment expenses [1].

Core Viewpoint - Baoming Technology (002992.SZ) expects a net profit attributable to shareholders of 9.5 million to 12 million yuan for the year 2025, representing a year-on-year growth of 112.44% to 115.72% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 5.5 million and 8 million yuan, indicating a year-on-year increase of 106.49% to 109.44% [1] Financial Performance - The company has implemented various measures to reduce costs and increase efficiency, leading to an improvement in the gross profit margin of its main business products [1] - The overall profitability of the company has seen a certain degree of enhancement, contributing to the improvement in operating performance [1]

Core Viewpoint - Gansu Longshen Rongfa Pharmaceutical Co., Ltd. expects a net profit of 42 million to 48.5 million yuan for the fiscal year 2025, representing a growth of 79.59% to 107.38% compared to the same period in 2024, driven by cost control and supply chain management [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 42 million to 48.5 million yuan for 2025, marking a significant increase from the previous year [1] - Non-recurring gains and losses are expected to impact net profit by approximately 4 million yuan [1] Product and Market Position - The core support for the company's performance comes from its unique products, Yuanhu Zhiting Droplets and Xuanfei Zhiso Mixture, which maintain strong market positions [2] - A new production line for Xuanfei Zhiso Mixture with an annual capacity of 50 million boxes has passed GMP compliance checks and commenced production in August 2025 [2] Research and Development - The company has upgraded its research facilities and established multiple R&D platforms, including a significant acquisition of 70% of Gansu Pharmaceutical Group Technology Innovation Research Institute [3] - The company is advancing its product development, including the registration application for a new drug, and has launched several health products to enhance its product portfolio [3] International and Diversification Efforts - The company achieved important milestones in internationalization, with its health product, Huangqi Danggui Capsules, receiving official certification in Macau, facilitating market expansion [4] - New medical products, including blood dialysis powder and concentrated solutions, have received regulatory approval, paving the way for future production and sales [4]

Group 1 - The company Tianchuang Fashion expects to achieve a net profit attributable to shareholders of the parent company between 12 million to 16 million yuan for the fiscal year 2025, marking a turnaround from loss to profit compared to the previous year [1] - The main reasons for the performance change include a focus on popular and trending product categories, effective collaboration within the research, production, and sales system, continuous cost reduction and efficiency improvement, and accelerated transformation and upgrading of the omnichannel strategy to enhance user consumption experience [1] Group 2 - The industry is witnessing a significant shift in battery technology, with semi-solid state batteries expected to be equipped in multiple new vehicles this year, indicating a year of iteration for power battery technology [1]

Core Insights - The article emphasizes the importance of optimizing payment solutions for businesses, particularly for small and medium-sized enterprises (SMEs), which often face challenges due to outdated payment systems and high costs [1][2]. Group 1: Payment Challenges - Over two-thirds of online shopping cart abandonment is attributed to poor payment processes, leading to revenue loss and negative customer experiences [1]. - Payment costs typically account for 3% to 5% of total revenue, significantly impacting profitability, yet contracts with payment solution providers are rarely reviewed [1]. - SMEs often lack specialized knowledge in payment systems, resulting in substantial annual financial losses [1]. Group 2: Solution Implementation - A collaborative approach between Prokura and Kearney was employed to create scalable payment solutions that ensure cost transparency and value release [2]. - The initial assessment involved collecting expenditure data and conducting expert interviews to identify unfavorable contract terms and complex fee structures [3]. - The assessment revealed hidden costs, such as foreign exchange transaction fees, which constituted over 50% of total costs but were not clearly stated in invoices [3]. Group 3: Strategy Development - The payment model was optimized to align with the company's growth trajectory and international customer base, focusing on minimizing foreign exchange fees [4]. - Benchmarking was conducted to identify areas with the highest potential for improvement, setting ambitious yet realistic negotiation targets [4]. Group 4: Negotiation and Implementation - Negotiation was a critical phase, leveraging extensive experience to create personalized negotiation strategies that maximized leverage and potential benefits [6]. - The company successfully renegotiated agreements with suppliers, achieving better pricing, flexible payment plans, and improved service levels [6]. - A new payment model was established, along with processes for ongoing collaboration with payment partners to explore further optimization opportunities [6]. Group 5: Results and Impact - The optimization of payment settings led to a 30% reduction in costs for the electronic tablet company, achieved through enhanced cost transparency and future demand forecasting [8]. - Other clients experienced cost reductions of 8% to 12% by examining payment costs comprehensively, including automation and fraud rates [8]. - The focus on payment settings not only improved cost transparency but also enhanced operational savings and value creation, leading to a 3% to 5% increase in conversion rates [9].

Core Viewpoint - Zhongke Tongda (688038.SH) expects to significantly reduce its net loss for the fiscal year 2025, with projections indicating a loss of between -5 million to -3.5 million yuan, representing a reduction in loss of 72.38% to 80.67% compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to the parent company, excluding non-recurring gains and losses, of between -7.7 million to -6.2 million yuan for 2025, which reflects a reduction in loss of 60.89% to 68.50% year-on-year [1] - The expected reduction in losses is attributed to several factors, including a focus on software business expansion, which has led to an increase in the proportion of pure software business revenue and an improvement in overall gross margin [1] Operational Adjustments - The company has proactively reduced low-quality integration projects to control risks, which has contributed to a decline in operating revenue year-on-year [1] - Measures taken to optimize organizational structure, strengthen cost control, and enhance operational efficiency have resulted in a decrease in period expenses compared to the previous year [1] Cash Flow and Receivables - The company has actively promoted the recovery of accounts receivable, resulting in an increase in sales cash receipts compared to last year, which has positively impacted the net operating cash flow [1] - The credit impairment losses, which were conservatively estimated, have significantly decreased compared to the same period last year [1]